Skip to main content
Erschienen in: Journal of Neuro-Oncology 2/2008

01.04.2008 | Clinical-Patient Studies

Proton magnetic resonance spectroscopy predicts proliferative activity in diffuse low-grade gliomas

verfasst von: Remy Guillevin, Carole Menuel, Hugues Duffau, Michel Kujas, Laurent Capelle, Agnès Aubert, Sophie Taillibert, Ahmed Idbaih, Joan Pallud, Giovanni Demarco, Robert Costalat, Khê Hoang-Xuan, Jacques Chiras, Jean-Noel Vallée

Erschienen in: Journal of Neuro-Oncology | Ausgabe 2/2008

Einloggen, um Zugang zu erhalten

Abstract

The aim of the study was to investigate the ability of 1HMRS to reflect proliferative activity of diffuse low-grade gliomas (WHO grade II). Between November 2002 and March 2007, a prospective study was performed on consecutive patients with suspected supratentorial hemispheric diffuse low-grade tumors. All the patients underwent MR examination using uniform procedures, and then surgical resection or biopsy within 2 weeks of the MR examination. Proliferative activity of the tumors was assessed by Ki-67 immunochemistry (Mb-1) on paraffin embedded tumor sections. Spectroscopic data was compared with Ki-67 labeling index and other histologic data such as histological subtype, cellular atypia, cellular density using univariate and multivariate analysis. 82 of 97 consecutive patients had histologically confirmed WHO grade 2 gliomas. Ki-67 proliferation index (PI) was correlated with specific spectral patterns: (1) low PI (<4%) was associated with increased Cho/Cr and absence of both free lipids or lactates; (2) intermediate PI (4–8%) was associated with resonance of lactates; and (3) high PI (>8%) was characterized by a resonance of free lipids. On multivariate analysis, resonance of lactates and resonance of free lipids appeared as independent predictors of intermediate PI (< 0.001) and high PI (P < 0.001), respectively; moreover, free lipids resonance was correlated with cellular atypia (P < 0.05). This study suggests that 1HMRS is a reliable tool to evaluate the proliferation activity of WHO grade 2 glioma and to identify potentially more aggressive clinical behavior.
Literatur
1.
Zurück zum Zitat Alger JR et al (1990) Metabolism of human gliomas: assessment with H-1 MR spectroscopy and F-18 fluorodeoxyglucose PET. Radiology 177(3):633–641PubMed Alger JR et al (1990) Metabolism of human gliomas: assessment with H-1 MR spectroscopy and F-18 fluorodeoxyglucose PET. Radiology 177(3):633–641PubMed
2.
Zurück zum Zitat Ott D, Hennig J, Ernst T (1993) Human brain tumors: assessment with in vivo proton MR spectroscopy. Radiology 186(3):745–752PubMed Ott D, Hennig J, Ernst T (1993) Human brain tumors: assessment with in vivo proton MR spectroscopy. Radiology 186(3):745–752PubMed
3.
Zurück zum Zitat Michaelis T et al (1993) Absolute concentrations of metabolites in the adult human brain in vivo: quantification of localized proton MR spectra. Radiology 187(1):219–227PubMed Michaelis T et al (1993) Absolute concentrations of metabolites in the adult human brain in vivo: quantification of localized proton MR spectra. Radiology 187(1):219–227PubMed
4.
Zurück zum Zitat Miller BL (1991) A review of chemical issues in 1H NMR spectroscopy: N-acetyl-l-aspartate, creatine and choline. NMR Biomed 4(2):47–52PubMedCrossRef Miller BL (1991) A review of chemical issues in 1H NMR spectroscopy: N-acetyl-l-aspartate, creatine and choline. NMR Biomed 4(2):47–52PubMedCrossRef
5.
Zurück zum Zitat Urenjak J et al (1993) Proton nuclear magnetic resonance spectroscopy unambiguously identifies different neural cell types. J Neurosci 13(3):981–989PubMed Urenjak J et al (1993) Proton nuclear magnetic resonance spectroscopy unambiguously identifies different neural cell types. J Neurosci 13(3):981–989PubMed
6.
Zurück zum Zitat Kemp GJ (2000) Non-invasive methods for studying brain energy metabolism: what they show and what it means. Dev Neurosci 22(5–6):418–428PubMedCrossRef Kemp GJ (2000) Non-invasive methods for studying brain energy metabolism: what they show and what it means. Dev Neurosci 22(5–6):418–428PubMedCrossRef
7.
Zurück zum Zitat Croteau D et al (2001) Correlation between magnetic resonance spectroscopy imaging and image-guided biopsies: semiquantitative and qualitative histopathological analyses of patients with untreated glioma. Neurosurgery 49(4):823–829PubMedCrossRef Croteau D et al (2001) Correlation between magnetic resonance spectroscopy imaging and image-guided biopsies: semiquantitative and qualitative histopathological analyses of patients with untreated glioma. Neurosurgery 49(4):823–829PubMedCrossRef
8.
Zurück zum Zitat Dowling C et al (2001) Preoperative proton MR spectroscopic imaging of brain tumors: correlation with histopathologic analysis of resection specimens. Am J Neuroradiol 22(4):604–612PubMed Dowling C et al (2001) Preoperative proton MR spectroscopic imaging of brain tumors: correlation with histopathologic analysis of resection specimens. Am J Neuroradiol 22(4):604–612PubMed
9.
Zurück zum Zitat Vuori K et al (2004) Low-grade gliomas and focal cortical developmental malformations: differentiation with proton MR spectroscopy. Radiology 230(3):703–708PubMedCrossRef Vuori K et al (2004) Low-grade gliomas and focal cortical developmental malformations: differentiation with proton MR spectroscopy. Radiology 230(3):703–708PubMedCrossRef
10.
Zurück zum Zitat Herminghaus S et al (2003) Determination of histopathological tumor grade in neuroepithelial brain tumors by using spectral pattern analysis of in vivo spectroscopic data. J Neurosurg 98(1):74–81PubMed Herminghaus S et al (2003) Determination of histopathological tumor grade in neuroepithelial brain tumors by using spectral pattern analysis of in vivo spectroscopic data. J Neurosurg 98(1):74–81PubMed
11.
Zurück zum Zitat Yang D et al (2002) Cerebral gliomas: prospective comparison of multivoxel 2D chemical-shift imaging proton MR spectroscopy, echoplanar perfusion and diffusion-weighted MRI. Neuroradiology 44(8):656–666PubMedCrossRef Yang D et al (2002) Cerebral gliomas: prospective comparison of multivoxel 2D chemical-shift imaging proton MR spectroscopy, echoplanar perfusion and diffusion-weighted MRI. Neuroradiology 44(8):656–666PubMedCrossRef
12.
Zurück zum Zitat Mandonnet E et al (2003) Continuous growth of mean tumor diameter in a subset of grade II gliomas. Ann Neurol 53(4):524–528PubMedCrossRef Mandonnet E et al (2003) Continuous growth of mean tumor diameter in a subset of grade II gliomas. Ann Neurol 53(4):524–528PubMedCrossRef
13.
Zurück zum Zitat Hoyt JW et al (1995) Analysis of proliferative grade in glial neoplasms using antibodies to the Ki-67 defined antigen and PCNA in formalin fixed, deparaffinized tissues. J Neurooncol 24(2):163–169PubMedCrossRef Hoyt JW et al (1995) Analysis of proliferative grade in glial neoplasms using antibodies to the Ki-67 defined antigen and PCNA in formalin fixed, deparaffinized tissues. J Neurooncol 24(2):163–169PubMedCrossRef
14.
Zurück zum Zitat Steck K, el-Naggar AK (1994) Comparative flow cytometric analysis of Ki-67 and proliferating cell nuclear antigen (PCNA) in solid neoplasms. Cytometry 17(3):258–265PubMedCrossRef Steck K, el-Naggar AK (1994) Comparative flow cytometric analysis of Ki-67 and proliferating cell nuclear antigen (PCNA) in solid neoplasms. Cytometry 17(3):258–265PubMedCrossRef
15.
Zurück zum Zitat Kleihues P, Sobin LH (2000) World Health Organization classification of tumors. Cancer 88(12):2887PubMedCrossRef Kleihues P, Sobin LH (2000) World Health Organization classification of tumors. Cancer 88(12):2887PubMedCrossRef
16.
Zurück zum Zitat Czernicki Z et al (2000) Malignancy of brain tumors evaluated by proton magnetic resonance spectroscopy (1H-MRS) in vitro. Acta Neurochir Suppl 76:17–20PubMed Czernicki Z et al (2000) Malignancy of brain tumors evaluated by proton magnetic resonance spectroscopy (1H-MRS) in vitro. Acta Neurochir Suppl 76:17–20PubMed
17.
Zurück zum Zitat Isobe T et al (2002) Quantification of cerebral metabolites in glioma patients with proton MR spectroscopy using T2 relaxation time correction. Magn Reson Imaging 20(4):343–349PubMedCrossRef Isobe T et al (2002) Quantification of cerebral metabolites in glioma patients with proton MR spectroscopy using T2 relaxation time correction. Magn Reson Imaging 20(4):343–349PubMedCrossRef
18.
Zurück zum Zitat Tedeschi G et al (1997) Increased choline signal coinciding with malignant degeneration of cerebral gliomas: a serial proton magnetic resonance spectroscopy imaging study. J Neurosurg 87(4):516–524PubMed Tedeschi G et al (1997) Increased choline signal coinciding with malignant degeneration of cerebral gliomas: a serial proton magnetic resonance spectroscopy imaging study. J Neurosurg 87(4):516–524PubMed
19.
Zurück zum Zitat Piepmeier JM (2001) Cerebral gliomas: how tumor biology affects management. Clin Neurosurg 48:3–9PubMed Piepmeier JM (2001) Cerebral gliomas: how tumor biology affects management. Clin Neurosurg 48:3–9PubMed
20.
Zurück zum Zitat Pallud J et al (2006) Prognostic value of initial magnetic resonance imaging growth rates for World Health Organization grade II gliomas. Ann Neurol 60(3):380–383PubMedCrossRef Pallud J et al (2006) Prognostic value of initial magnetic resonance imaging growth rates for World Health Organization grade II gliomas. Ann Neurol 60(3):380–383PubMedCrossRef
21.
Zurück zum Zitat Piepmeier J et al (1996) Variations in the natural history and survival of patients with supratentorial low-grade astrocytomas. Neurosurgery 38(5):872–878 (discussion 878–879)PubMedCrossRef Piepmeier J et al (1996) Variations in the natural history and survival of patients with supratentorial low-grade astrocytomas. Neurosurgery 38(5):872–878 (discussion 878–879)PubMedCrossRef
22.
Zurück zum Zitat Louis DN et al (1991) Proliferating cell nuclear antigen and Ki-67 immunohistochemistry in brain tumors: a comparative study. Acta Neuropathol (Berl) 81(6):675–679CrossRef Louis DN et al (1991) Proliferating cell nuclear antigen and Ki-67 immunohistochemistry in brain tumors: a comparative study. Acta Neuropathol (Berl) 81(6):675–679CrossRef
23.
Zurück zum Zitat Neder L et al (2004) MIB-1 labeling index in astrocytic tumors–a clinicopathologic study. Clin Neuropathol 23(6):262–270PubMed Neder L et al (2004) MIB-1 labeling index in astrocytic tumors–a clinicopathologic study. Clin Neuropathol 23(6):262–270PubMed
24.
Zurück zum Zitat Wakimoto H et al (1996) Prognostic significance of Ki-67 labeling indices obtained using MIB-1 monoclonal antibody in patients with supratentorial astrocytomas. Cancer 77(2):373–380PubMedCrossRef Wakimoto H et al (1996) Prognostic significance of Ki-67 labeling indices obtained using MIB-1 monoclonal antibody in patients with supratentorial astrocytomas. Cancer 77(2):373–380PubMedCrossRef
25.
Zurück zum Zitat Daumas-Duport C et al (1988) Grading of astrocytomas. A simple and reproducible method. Cancer 62(10):2152–2165PubMedCrossRef Daumas-Duport C et al (1988) Grading of astrocytomas. A simple and reproducible method. Cancer 62(10):2152–2165PubMedCrossRef
26.
Zurück zum Zitat Kondziolka D, Lunsford LD, Martinez AJ (1993) Unreliability of contemporary neurodiagnostic imaging in evaluating suspected adult supratentorial (low-grade) astrocytoma. J Neurosurg 79(4):533–536PubMedCrossRef Kondziolka D, Lunsford LD, Martinez AJ (1993) Unreliability of contemporary neurodiagnostic imaging in evaluating suspected adult supratentorial (low-grade) astrocytoma. J Neurosurg 79(4):533–536PubMedCrossRef
27.
Zurück zum Zitat Cao Y et al (2006) Physiologic and metabolic magnetic resonance imaging in gliomas. J Clin Oncol 24(8):1228–1235PubMedCrossRef Cao Y et al (2006) Physiologic and metabolic magnetic resonance imaging in gliomas. J Clin Oncol 24(8):1228–1235PubMedCrossRef
28.
Zurück zum Zitat Julia-Sape M et al (2006) Comparison between neuroimaging classifications and histopathological diagnoses using an international multicenter brain tumor magnetic resonance imaging database. J Neurosurg 105(1):6–14PubMedCrossRef Julia-Sape M et al (2006) Comparison between neuroimaging classifications and histopathological diagnoses using an international multicenter brain tumor magnetic resonance imaging database. J Neurosurg 105(1):6–14PubMedCrossRef
29.
Zurück zum Zitat Lev MH et al (2004) Glial tumor grading and outcome prediction using dynamic spin-echo MR susceptibility mapping compared with conventional contrast-enhanced MR: confounding effect of elevated rCBV of oligodendrogliomas [corrected]. Am J Neuroradiol 25(2):214–221PubMed Lev MH et al (2004) Glial tumor grading and outcome prediction using dynamic spin-echo MR susceptibility mapping compared with conventional contrast-enhanced MR: confounding effect of elevated rCBV of oligodendrogliomas [corrected]. Am J Neuroradiol 25(2):214–221PubMed
30.
Zurück zum Zitat Rees J (2003) Advances in magnetic resonance imaging of brain tumours. Curr Opin Neurol 16(6):643–650PubMedCrossRef Rees J (2003) Advances in magnetic resonance imaging of brain tumours. Curr Opin Neurol 16(6):643–650PubMedCrossRef
31.
Zurück zum Zitat Onda K et al (1994) Correlation between the bromodeoxyuridine labeling index and the MIB-1 and Ki-67 proliferating cell indices in cerebral gliomas. Cancer 74(7):1921–1926PubMedCrossRef Onda K et al (1994) Correlation between the bromodeoxyuridine labeling index and the MIB-1 and Ki-67 proliferating cell indices in cerebral gliomas. Cancer 74(7):1921–1926PubMedCrossRef
32.
Zurück zum Zitat Matsumura A et al (2005) Correlation between choline and MIB-1 index in human gliomas. A quantitative in proton MR spectroscopy study. J Clin Neurosci 12(4):416–420PubMedCrossRef Matsumura A et al (2005) Correlation between choline and MIB-1 index in human gliomas. A quantitative in proton MR spectroscopy study. J Clin Neurosci 12(4):416–420PubMedCrossRef
33.
Zurück zum Zitat Shimizu H et al (2000) Correlation between choline level measured by proton MR spectroscopy and Ki-67 labeling index in gliomas. Am J Neuroradiol 21(4):659–665PubMed Shimizu H et al (2000) Correlation between choline level measured by proton MR spectroscopy and Ki-67 labeling index in gliomas. Am J Neuroradiol 21(4):659–665PubMed
34.
Zurück zum Zitat Law M et al (2006) Perfusion magnetic resonance imaging predicts patient outcome as an adjunct to histopathology: a second reference standard in the surgical and nonsurgical treatment of low-grade gliomas. Neurosurgery 58(6):1099–1107 (discussion 1099–1107)PubMedCrossRef Law M et al (2006) Perfusion magnetic resonance imaging predicts patient outcome as an adjunct to histopathology: a second reference standard in the surgical and nonsurgical treatment of low-grade gliomas. Neurosurgery 58(6):1099–1107 (discussion 1099–1107)PubMedCrossRef
35.
Zurück zum Zitat Cha S et al (2003) Dynamic, contrast-enhanced perfusion MRI in mouse gliomas: correlation with histopathology. Magn Reson Med 49(5):848–855PubMedCrossRef Cha S et al (2003) Dynamic, contrast-enhanced perfusion MRI in mouse gliomas: correlation with histopathology. Magn Reson Med 49(5):848–855PubMedCrossRef
36.
Zurück zum Zitat Shin JH et al (2002) Using relative cerebral blood flow and volume to evaluate the histopathologic grade of cerebral gliomas: preliminary results. Am J Roentgenol 179(3):783–789 Shin JH et al (2002) Using relative cerebral blood flow and volume to evaluate the histopathologic grade of cerebral gliomas: preliminary results. Am J Roentgenol 179(3):783–789
37.
Zurück zum Zitat Sugahara T et al (1998) Correlation of MR imaging-determined cerebral blood volume maps with histologic and angiographic determination of vascularity of gliomas. Am J Roentgenol 171(6):1479–1486 Sugahara T et al (1998) Correlation of MR imaging-determined cerebral blood volume maps with histologic and angiographic determination of vascularity of gliomas. Am J Roentgenol 171(6):1479–1486
38.
Zurück zum Zitat Castillo M, Kwock L, Mukherji SK (1996) Clinical applications of proton MR spectroscopy. Am J Neuroradiol 17(1):1–15PubMed Castillo M, Kwock L, Mukherji SK (1996) Clinical applications of proton MR spectroscopy. Am J Neuroradiol 17(1):1–15PubMed
39.
Zurück zum Zitat Danielsen ER, Ross B (1999) Magnetic resonance spectroscopy diagnosis of neurological diseases (Book). Marcel Dekker, INC. Editor, New York, Basel Danielsen ER, Ross B (1999) Magnetic resonance spectroscopy diagnosis of neurological diseases (Book). Marcel Dekker, INC. Editor, New York, Basel
40.
Zurück zum Zitat Leclerc X, Huisman TA, Sorensen AG (2002) The potential of proton magnetic resonance spectroscopy ((1)H-MRS) in the diagnosis and management of patients with brain tumors. Curr Opin Oncol 14(3):292–298PubMedCrossRef Leclerc X, Huisman TA, Sorensen AG (2002) The potential of proton magnetic resonance spectroscopy ((1)H-MRS) in the diagnosis and management of patients with brain tumors. Curr Opin Oncol 14(3):292–298PubMedCrossRef
41.
Zurück zum Zitat Nafe R et al (2003) Preoperative proton-MR spectroscopy of gliomas—correlation with quantitative nuclear morphology in surgical specimen. J Neurooncol 63(3):233–245PubMedCrossRef Nafe R et al (2003) Preoperative proton-MR spectroscopy of gliomas—correlation with quantitative nuclear morphology in surgical specimen. J Neurooncol 63(3):233–245PubMedCrossRef
42.
Zurück zum Zitat Law M et al (2003) Glioma grading: sensitivity, specificity, and predictive values of perfusion MR imaging and proton MR spectroscopic imaging compared with conventional MR imaging. Am J Neuroradiol 24(10):1989–1998PubMed Law M et al (2003) Glioma grading: sensitivity, specificity, and predictive values of perfusion MR imaging and proton MR spectroscopic imaging compared with conventional MR imaging. Am J Neuroradiol 24(10):1989–1998PubMed
43.
Zurück zum Zitat Reijneveld JC et al (2005) Proton MRS imaging in the follow-up of patients with suspected low-grade gliomas. Neuroradiology 47(12):887–891PubMedCrossRef Reijneveld JC et al (2005) Proton MRS imaging in the follow-up of patients with suspected low-grade gliomas. Neuroradiology 47(12):887–891PubMedCrossRef
44.
Zurück zum Zitat Duffau H et al (2005) Contribution of intraoperative electrical stimulations in surgery of low grade gliomas: a comparative study between two series without (1985–96) and with (1996–2003) functional mapping in the same institution. J Neurol Neurosurg Psychiatry 76(6):845–851PubMedCrossRef Duffau H et al (2005) Contribution of intraoperative electrical stimulations in surgery of low grade gliomas: a comparative study between two series without (1985–96) and with (1996–2003) functional mapping in the same institution. J Neurol Neurosurg Psychiatry 76(6):845–851PubMedCrossRef
45.
Zurück zum Zitat Hoang-Xuan K et al (2004) Temozolomide as initial treatment for adults with low-grade oligodendrogliomas or oligoastrocytomas and correlation with chromosome 1p deletions. J Clin Oncol 22(15):3133–3138PubMedCrossRef Hoang-Xuan K et al (2004) Temozolomide as initial treatment for adults with low-grade oligodendrogliomas or oligoastrocytomas and correlation with chromosome 1p deletions. J Clin Oncol 22(15):3133–3138PubMedCrossRef
46.
Zurück zum Zitat Van den Bent MJ et al (2003) Phase II study of first-line chemotherapy with temozolomide in recurrent oligodendroglial tumors: the European Organization for Research and Treatment of Cancer Brain Tumor Group Study 26971. J Clin Oncol 21(13):2525–2528PubMedCrossRef Van den Bent MJ et al (2003) Phase II study of first-line chemotherapy with temozolomide in recurrent oligodendroglial tumors: the European Organization for Research and Treatment of Cancer Brain Tumor Group Study 26971. J Clin Oncol 21(13):2525–2528PubMedCrossRef
47.
Zurück zum Zitat Van den Bent MJ (2003) Can chemotherapy replace radiotherapy in low-grade gliomas? Time for randomized studies. Semin Oncol 30(6 suppl 19):39–44PubMed Van den Bent MJ (2003) Can chemotherapy replace radiotherapy in low-grade gliomas? Time for randomized studies. Semin Oncol 30(6 suppl 19):39–44PubMed
Metadaten
Titel
Proton magnetic resonance spectroscopy predicts proliferative activity in diffuse low-grade gliomas
verfasst von
Remy Guillevin
Carole Menuel
Hugues Duffau
Michel Kujas
Laurent Capelle
Agnès Aubert
Sophie Taillibert
Ahmed Idbaih
Joan Pallud
Giovanni Demarco
Robert Costalat
Khê Hoang-Xuan
Jacques Chiras
Jean-Noel Vallée
Publikationsdatum
01.04.2008
Verlag
Springer US
Erschienen in
Journal of Neuro-Oncology / Ausgabe 2/2008
Print ISSN: 0167-594X
Elektronische ISSN: 1573-7373
DOI
https://doi.org/10.1007/s11060-007-9508-y

Weitere Artikel der Ausgabe 2/2008

Journal of Neuro-Oncology 2/2008 Zur Ausgabe

Leitlinien kompakt für die Neurologie

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Frühe Alzheimertherapie lohnt sich

25.04.2024 AAN-Jahrestagung 2024 Nachrichten

Ist die Tau-Last noch gering, scheint der Vorteil von Lecanemab besonders groß zu sein. Und beginnen Erkrankte verzögert mit der Behandlung, erreichen sie nicht mehr die kognitive Leistung wie bei einem früheren Start. Darauf deuten neue Analysen der Phase-3-Studie Clarity AD.

Viel Bewegung in der Parkinsonforschung

25.04.2024 Parkinson-Krankheit Nachrichten

Neue arznei- und zellbasierte Ansätze, Frühdiagnose mit Bewegungssensoren, Rückenmarkstimulation gegen Gehblockaden – in der Parkinsonforschung tut sich einiges. Auf dem Deutschen Parkinsonkongress ging es auch viel um technische Innovationen.

Demenzkranke durch Antipsychotika vielfach gefährdet

23.04.2024 Demenz Nachrichten

Wenn Demenzkranke aufgrund von Symptomen wie Agitation oder Aggressivität mit Antipsychotika behandelt werden, sind damit offenbar noch mehr Risiken verbunden als bislang angenommen.

Update Neurologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.